Search

Your search keyword '"Yong-Yeon Cho"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Yong-Yeon Cho" Remove constraint Author: "Yong-Yeon Cho" Topic humans Remove constraint Topic: humans
82 results on '"Yong-Yeon Cho"'

Search Results

1. Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells

2. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases

3. Stat2 stability regulation: an intersection between immunity and carcinogenesis

4. Beyond hydrophilic polymers in amphiphilic polymer-based self-assembled NanoCarriers: Small hydrophilic carboxylate-capped disulfide drug delivery system and its multifunctionality and multispatial targetability

5. Pharmacokinetics of α-amanitin in mice using liquid chromatography-high resolution mass spectrometry and

6. FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation

7. Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules

8. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis

9. Mitochondria-targeted drug delivery in cancers

10. Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells

11. Simultaneous quantification of 18 saturated and unsaturated fatty acids and 7 sterols as their tert-butyldimethylsilyl derivatives in human saliva using gas chromatography-tandem mass spectrometry

12. Targeting PRPK and TOPK for skin cancer prevention and therapy

13. Effects of the Physicochemical, Colloidal, and Biological Characteristics of Different Polymer Structures between α-Poly(<scp>l</scp>-lysine) and ε-Poly(<scp>l</scp>-lysine) on Polymeric Gene Delivery

14. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis

15. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis

16. Controlling complexation/decomplexation and sizes of polymer-based electrostatic pDNA polyplexes is one of the key factors in effective transfection

17. NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β–NDRG2–PP2A Complex Formation

18. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity

19. In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)

20. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells

21. Oxidized Phospholipids in Tumor Microenvironment Stimulate Tumor Metastasis via Regulation of Autophagy

22. Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway

23. Loss-of-function screens of druggable targetome against cancer stem–like cells

24. Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling

25. Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome

26. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation

27. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

28. Molecular Targeting of ERKs/RSK2 Signaling in Cancers

29. JNK1 and 2 play a negative role in reprogramming to pluripotent stem cells by suppressing Klf4 activity

30. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters

31. Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis

32. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation

33. RSK2 and its binding partners in cell proliferation, transformation and cancer development

34. Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5′-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes

35. RSK2 as a key regulator in human skin cancer

36. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4

37. Phosphorylation of H2AX at Ser139 and a New Phosphorylation Site Ser16 by RSK2 Decreases H2AX Ubiquitination and Inhibits Cell Transformation

38. Phosphorylation of Sox2 Cooperates in Reprogramming to Pluripotent Stem Cells

39. A selective small-molecule inhibitor of c-JunN-terminal kinase 1

40. A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity

41. Cyclin-Dependent Kinase-3–Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation

42. The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development

43. Nuclear Factor of Activated T3 Is a Negative Regulator of Ras-JNK1/2-AP-1–Induced Cell Transformation

44. Kazinol-E is a specific inhibitor of ERK that suppresses the enrichment of a breast cancer stem-like cell population

45. Gastroenterology: Sweet's syndrome in a patient with acutely exacerbated ulcerative colitis

46. The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1

47. Theaflavin-3, 3′-digallate induces epidermal growth factor receptor downregulation

48. The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity

49. The p53 Protein Is a Novel Substrate of Ribosomal S6 Kinase 2 and a Critical Intermediary for Ribosomal S6 Kinase 2 and Histone H3 Interaction

50. Phosphorylation of Ser28 in Histone H3 Mediated by Mixed Lineage Kinase-like Mitogen-activated Protein Triple Kinase α

Catalog

Books, media, physical & digital resources